Home > Balance Sheet > NEULAND LABORATORIES

NEULAND LABORATORIES
Deferred Tax Assets / Liabilities

    Back to Balance Sheet
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Deferred Tax Assets / Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Deferred Tax Assets / Liabilities ₹73 Cr₹60 Cr₹58 Cr₹57 Cr₹60 Cr

What is the latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES ?

The latest Deferred Tax Assets / Liabilities ratio of NEULAND LABORATORIES is ₹73 Cr based on Mar2025 Consolidated results.
Year Deferred Tax Assets / Liabilities
Mar2025₹73 Cr
Mar2024₹60 Cr
Mar2023₹58 Cr
Mar2022₹57 Cr
Mar2021₹60 Cr

How is Deferred Tax Assets / Liabilities of NEULAND LABORATORIES Trending?

Years Deferred Tax Assets / Liabilities % Change
Mar2025 ₹73 Cr
20.49
Mar2024 ₹60 Cr
3.67
Mar2023 ₹58 Cr
2.82
Mar2022 ₹57 Cr
-5.12
Mar2021 ₹60 Cr -

Compare Deferred Tax Assets / Liabilities of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,762.6 Cr -2% -3.6% 11.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹420,531.0 Cr 1.3% 8.9% 6% Stock Analytics
DIVIS LABORATORIES ₹169,989.0 Cr 2.4% 6% 12.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹147,936.0 Cr -0.6% 9.4% 44.1% Stock Analytics
CIPLA ₹109,200.0 Cr 1.9% 2% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹108,057.0 Cr -0.4% 9.5% 10.5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-2%

-3.6%

11.3%

SENSEX

-3.7%

-2.5%

6.5%


You may also like the below Video Courses